SG11201807225VA - Novel prna three-way junctions - Google Patents
Novel prna three-way junctionsInfo
- Publication number
- SG11201807225VA SG11201807225VA SG11201807225VA SG11201807225VA SG11201807225VA SG 11201807225V A SG11201807225V A SG 11201807225VA SG 11201807225V A SG11201807225V A SG 11201807225VA SG 11201807225V A SG11201807225V A SG 11201807225VA SG 11201807225V A SG11201807225V A SG 11201807225VA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- norman
- prna
- pct
- english
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3519—Fusion with another nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/52—Physical structure branched
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662300517P | 2016-02-26 | 2016-02-26 | |
| PCT/US2017/019556 WO2017147557A1 (en) | 2016-02-26 | 2017-02-26 | Novel prna three-way junctions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201807225VA true SG11201807225VA (en) | 2018-09-27 |
Family
ID=59685710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201807225VA SG11201807225VA (en) | 2016-02-26 | 2017-02-26 | Novel prna three-way junctions |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10900035B2 (pt) |
| EP (1) | EP3419988A4 (pt) |
| JP (1) | JP2019510511A (pt) |
| CN (1) | CN109071591A (pt) |
| AU (1) | AU2017222690A1 (pt) |
| BR (1) | BR112018068247A2 (pt) |
| CA (1) | CA3015667A1 (pt) |
| IL (1) | IL261368A (pt) |
| SG (1) | SG11201807225VA (pt) |
| WO (1) | WO2017147557A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019156726A1 (en) | 2018-02-09 | 2019-08-15 | Ohio State Innovation Foundation | Rna nanostructures, methods of making, and uses thereof |
| US20190269728A1 (en) * | 2018-03-02 | 2019-09-05 | Sixfold Bioscience Ltd. | Compositions for delivery of cargo to cells |
| AU2019302604B2 (en) * | 2018-07-12 | 2023-11-02 | Bai Yao Zhi Da (Beijing) Nanobio Technology Co., Ltd. | Nucleic acid nanoparticles, pharmaceutical composition comprising same, drug comprising doxorubicin and preparation method thereof |
| WO2021220053A2 (en) | 2020-04-27 | 2021-11-04 | Sixfold Bioscience Ltd. | Compositions containing nucleic acid nanoparticles with modular functionality |
| WO2024069235A2 (en) | 2022-09-30 | 2024-04-04 | Sixfold Bioscience Ltd. | Compositions containing oligonucleotides with theranostic applications |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1366151T3 (da) * | 2000-08-23 | 2008-02-04 | Purdue Research Foundation | pRNA-kimærer |
| US20050266416A1 (en) * | 2002-09-18 | 2005-12-01 | Purdue Research Foundation | Molecular nanomotor |
| US9732337B2 (en) * | 2009-06-16 | 2017-08-15 | The United Stated of America, as represented by the Secretary, Department of Health & Human Services | RNA nanoparticles and nanotubes |
| WO2012094586A2 (en) * | 2011-01-07 | 2012-07-12 | Peixuan Guo | Synthetic non-covalently self-assembling bipartite prna chimeras |
| US9297013B2 (en) * | 2011-06-08 | 2016-03-29 | University Of Cincinnati | pRNA multivalent junction domain for use in stable multivalent RNA nanoparticles |
| CN106795517A (zh) * | 2014-06-19 | 2017-05-31 | 肯塔基大学研究基金会 | 基于rna的组合物及用于预防性和治疗性疗法的佐剂 |
-
2017
- 2017-02-26 CA CA3015667A patent/CA3015667A1/en not_active Abandoned
- 2017-02-26 US US16/079,476 patent/US10900035B2/en active Active
- 2017-02-26 WO PCT/US2017/019556 patent/WO2017147557A1/en active Application Filing
- 2017-02-26 EP EP17757401.9A patent/EP3419988A4/en not_active Withdrawn
- 2017-02-26 SG SG11201807225VA patent/SG11201807225VA/en unknown
- 2017-02-26 BR BR112018068247A patent/BR112018068247A2/pt not_active Application Discontinuation
- 2017-02-26 JP JP2018563766A patent/JP2019510511A/ja active Pending
- 2017-02-26 AU AU2017222690A patent/AU2017222690A1/en not_active Abandoned
- 2017-02-26 CN CN201780026258.0A patent/CN109071591A/zh active Pending
-
2018
- 2018-08-26 IL IL261368A patent/IL261368A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3419988A1 (en) | 2019-01-02 |
| AU2017222690A1 (en) | 2018-09-13 |
| CN109071591A (zh) | 2018-12-21 |
| BR112018068247A2 (pt) | 2019-01-15 |
| IL261368A (en) | 2018-10-31 |
| WO2017147557A1 (en) | 2017-08-31 |
| CA3015667A1 (en) | 2017-08-31 |
| EP3419988A4 (en) | 2019-11-27 |
| US20190055551A1 (en) | 2019-02-21 |
| JP2019510511A (ja) | 2019-04-18 |
| US10900035B2 (en) | 2021-01-26 |
| WO2017147557A8 (en) | 2018-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201807225VA (en) | Novel prna three-way junctions | |
| SG11201906395PA (en) | Blockchain based data processing method and device | |
| SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201806624XA (en) | Deposition of molybdenum thin films using a molybdenum carbonyl precursor | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201805044WA (en) | Compounds useful as kinase inhibitors | |
| SG11201804787UA (en) | Human immunodeficiency virus neutralizing antibodies | |
| SG11201804901WA (en) | Compounds for the treatment of cancer and inflammatory disease | |
| SG11201803897QA (en) | Pressure control device, dispenser comprising said pressure control device and method of manufacturing | |
| SG11201907364WA (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
| SG11201809830WA (en) | Selective reduction of cysteine-engineered antibodies | |
| SG11201806267QA (en) | Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose | |
| SG11201804890TA (en) | Bipyrazolyl derivatives useful for the treatment of autoimmune diseases | |
| SG11201407534PA (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
| SG11201500005SA (en) | Pyrimidine pyrazolyl derivatives | |
| SG11201804916PA (en) | Three-dimensional polymer networks with channels situated therein | |
| SG11202000333UA (en) | Bicyclic ketone compounds and methods of use thereof | |
| SG11201804867RA (en) | Coating compositions and treating method | |
| SG11201806393QA (en) | Use of gabaa receptor modulators for treatment of itch | |
| SG11201809432UA (en) | System, method and device for processing a transaction | |
| SG11201804629XA (en) | Compositions and methods for assessing the risk of cancer occurrence | |
| SG11201408685WA (en) | Antibacterial microelement chelates and the use thereof in animal feeds | |
| SG11201908605XA (en) | Antifouling article | |
| SG11201906807VA (en) | Compositions and methods for promoting hair growth with mpc1 inhibitors | |
| SG11201407208UA (en) | A method for dynamic generation and modification of an electronic entity architecture |